Trial Profile
Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles).
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Apr 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dystonia
- Focus Therapeutic Use
- 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.
- 18 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Jun 2009 New trial record